Cite

HARVARD Citation

    Papadavid, E. et al. (2019). Efficacy and safety of Brentuximab Vedotin in advanced cutaneous T‐Cell lymphomas patients. Journal of the European Academy of Dermatology and Venereology. pp. e223-e225. [Online]. 
  
Back to record